| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/24/1999 | WO1999030548A2 Method for the preparation of citalopram |
| 06/24/1999 | WO1999019305A3 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system |
| 06/24/1999 | WO1999018919A3 Topical compositions for regulating the oily/shiny appearance of skin |
| 06/24/1999 | WO1999017758A3 Treatment of sickle cell anemia crises with fructose-1,6-diphosphate as an analgesic drug |
| 06/24/1999 | WO1999016888A3 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 06/24/1999 | WO1999005155A3 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof |
| 06/24/1999 | WO1998052562A9 Pharmaceutical composition containing uscharidin or its analogues |
| 06/24/1999 | WO1998018951A8 Receptor-mediated gene transfer system for targeting tumor gene therapy |
| 06/24/1999 | DE19849228A1 Use of compositions containing vitamin E and chitosan |
| 06/24/1999 | DE19845246A1 Vitamin E compositions |
| 06/24/1999 | DE19756388A1 New 2-aryl-4-amino-6,7-di:methoxy-quinazoline derivatives useful as guanylate cyclase activators for treating cardiovascular diseases, etc. |
| 06/24/1999 | DE19756036A1 New indole amide derivatives |
| 06/24/1999 | CA2730373A1 Treatment of cancer having overexpression of erbb2 with anti-erbb2 antibodies and a hormonal chemotherapeutic agent |
| 06/24/1999 | CA2615701A1 Process for the preparation of 6-o-methyl erythromycin a using 9-hydroxy erythromycin derivatives |
| 06/24/1999 | CA2586240A1 Improved hmg coa reductase inhibitor extended release formulation |
| 06/24/1999 | CA2506802A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/24/1999 | CA2348660A1 Diagnostics and therapeutics for transmissible spongiform encephalopathy and methods for the manufacture of non-infective blood products and tissue derived products |
| 06/24/1999 | CA2315540A1 Agonists of metabotropic glutamate receptors and uses thereof |
| 06/24/1999 | CA2315370A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315268A1 Oligophrenin-1, its expression product, and the diagnostic and therapeutic applications thereof |
| 06/24/1999 | CA2315256A1 Needle-free injection of formulated nucleic acid molecules |
| 06/24/1999 | CA2315232A1 Integrin receptor antagonists |
| 06/24/1999 | CA2315224A1 Method for enhancing the absorption and transport of lipid soluble compounds using structured glycerides |
| 06/24/1999 | CA2315079A1 Substituted isoquinoline derivatives and their use as anticonvulsants |
| 06/24/1999 | CA2314993A1 Combination effective for the treatment of impotence |
| 06/24/1999 | CA2314968A1 Pharmaceutical compositions containing micronized bicyclic drugs |
| 06/24/1999 | CA2314967A1 Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use |
| 06/24/1999 | CA2314965A1 Hydrate of 5-[4-[2- (n-methyl-n- (2-pyridil)amino) ethoxy]benzyl] thiazolidine-2, 4-dione maleic acid salt |
| 06/24/1999 | CA2314954A1 Apoptosis inhibitors |
| 06/24/1999 | CA2314948A1 Potassium channel openers |
| 06/24/1999 | CA2314885A1 Pharmaceutical compositions for mucolysis and treatment of inflammation |
| 06/24/1999 | CA2314490A1 Novel bispidine antiarrhythmic compounds |
| 06/24/1999 | CA2314395A1 Use of substituted amidino compounds in the treatment of chronic obstructive pulmonary disease |
| 06/24/1999 | CA2314369A1 Prostaglandin e2/f2.alpha. combination for treating impotence and enhancing sexual arousal |
| 06/24/1999 | CA2314355A1 Use of pyrazolo ¢3,4-b! pyridine as cyclin dependent kinase inhibitors |
| 06/24/1999 | CA2314335A1 Purine derivatives having phosphodiesterase iv inhibition activity |
| 06/24/1999 | CA2314259A1 Multicatalytic protease inhibitors for use as anti-tumor agents |
| 06/24/1999 | CA2314141A1 Glucose regulated gene |
| 06/24/1999 | CA2314139A1 Cephalosporin antibiotics |
| 06/24/1999 | CA2314111A1 Dihydrobenzofurans |
| 06/24/1999 | CA2314107A1 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical |
| 06/24/1999 | CA2313797A1 Heterocyclic cytotoxic agents |
| 06/24/1999 | CA2313776A1 Triazine angiogenesis inhibitors |
| 06/24/1999 | CA2313651A1 Benzamine derivatives |
| 06/24/1999 | CA2313649A1 Novel metalloproteinase inhibitors |
| 06/24/1999 | CA2313239A1 Azulene hydroxamic acid derivatives as metalloprotein inhibitors |
| 06/24/1999 | CA2313212A1 Modulators of cysteine protease |
| 06/24/1999 | CA2313125A1 Quinolinepiperazine and quinolinepiperidine derivatives, their preparation and their use as combined 5-ht1a, 5-ht1b and 5-ht1d receptor antagonists |
| 06/24/1999 | CA2313049A1 Cyclooxygenase-2 inhibition |
| 06/24/1999 | CA2313005A1 Method to enhance an immune response of nucleic acid vaccination |
| 06/24/1999 | CA2313004A1 3-substituted adenines via2-thioxanthines |
| 06/24/1999 | CA2312940A1 Antipicornaviral compounds and methods for their use and preparation |
| 06/24/1999 | CA2312406A1 Drugs augmenting nkt cells |
| 06/24/1999 | CA2312347A1 Use of an aromatase inhibitor in the treatment of decreased androgen to estrogen ratio and detrusor urethral sphincter dyssynergia in men and method to study the dyssynergia in male rodents |
| 06/24/1999 | CA2311932A1 A method for the prevention and treatment of stunned myocardium |
| 06/24/1999 | CA2309080A1 Local delivery of therapeutic agents |
| 06/24/1999 | CA2304612A1 Statin-carboxyalkylether combinations |
| 06/24/1999 | CA2299397A1 Antihyperlipidemic statin-lp(a) inhibitor combinations |
| 06/24/1999 | CA2281650A1 Methods for improving the health of hair and scalp |
| 06/24/1999 | CA2280705A1 3-piperidyl-4-oxoquinazoline derivatives and pharmaceutical compositionscomprising the same |
| 06/23/1999 | EP0924519A2 Process for determining of a dosage regime for thrombin inhibitors |
| 06/23/1999 | EP0924295A2 DNA encoding neospora dihydrofolate reductase-thymidylate synthase |
| 06/23/1999 | EP0924246A1 Uses of Isoindolinone derivatives |
| 06/23/1999 | EP0924212A1 Chrolactomycin compound |
| 06/23/1999 | EP0924211A2 1,2 bridged 1,4-dihydropyridines as selective potassium channel modulators |
| 06/23/1999 | EP0924210A1 2-(1-(1,3-Thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives |
| 06/23/1999 | EP0924209A1 Hypoglycemic imidazoline compounds |
| 06/23/1999 | EP0924205A1 Arylpiperazines having activity at the serotonin 1a receptor |
| 06/23/1999 | EP0924201A1 Tricyclic-substituted pyrazolyl benzenesulfonamides and their use as cyclooxygenase II inhibitors |
| 06/23/1999 | EP0923942A1 5alpha-REDUCTASE INHIBITORY PREPARATION FOR ORAL ADMINISTRATION, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF |
| 06/23/1999 | EP0923941A2 Remedies for myeloma to be used together with nitrogen mustard antitumor agents |
| 06/23/1999 | EP0923935A1 External preparation for curing lesioned tissues |
| 06/23/1999 | EP0923934A1 Modified release matrix formulation of cefaclor and cephalexin |
| 06/23/1999 | EP0923933A1 Substituted pyrazolyl benzenesulfonamides for use in the treatment of inflammation |
| 06/23/1999 | EP0923932A1 Composition containing antitumor agent |
| 06/23/1999 | EP0923740A2 Methods and compositions for the detection of cervical cancer |
| 06/23/1999 | EP0923646A1 Vaccine compositions and methods useful in inducing immune protection against arthritogenic peptides involved in the pathogenesis of rheumatoid arthritis |
| 06/23/1999 | EP0923642A1 Active survival domains of igf-ir and methods of use |
| 06/23/1999 | EP0923606A1 ANTIGENIC FUSIONPROTEIN CARRYING GAL$g(a)1,3GAL EPITOPES |
| 06/23/1999 | EP0923604A1 Cysteine-containing or methioine-containing peptides with immunomodulatory effects |
| 06/23/1999 | EP0923600A2 Novel cationic amphiphilic lipids for liposomal gene transfer |
| 06/23/1999 | EP0923594A1 Bromotiacumicin compounds |
| 06/23/1999 | EP0923592A1 Methods for purifying nucleic acids |
| 06/23/1999 | EP0923585A1 Phosphinate based inhibitors of matrix metalloproteases |
| 06/23/1999 | EP0923583A1 Method for producing epothilones, and intermediate products obtained during the production process |
| 06/23/1999 | EP0923582A1 Substituted 6,5-hetero-bicyclic derivatives |
| 06/23/1999 | EP0923581A1 4-substituted beta-carbolines as immunomodulators |
| 06/23/1999 | EP0923580A1 Thiazolidinedione compounds having antidiabetic, hypolipidaemic, antihypertensive properties, process for their preparation and pharmaceutical compositions thereof |
| 06/23/1999 | EP0923576A1 4-aminoethoxy-indolone derivatives as dopamine d2 agonists |
| 06/23/1999 | EP0923573A1 Preparation of aminomethyl-phenylimidazoles |
| 06/23/1999 | EP0923570A1 Pyridyl alkene- and pyridyl alkine- acid amides as cytostatics and immunosuppressives |
| 06/23/1999 | EP0923569A1 Butyric acid matrix metalloproteinase inhibitors |
| 06/23/1999 | EP0923568A1 Novel benzofuran-4-carboxamides |
| 06/23/1999 | EP0923567A1 Benzylamine derivatives, their preparation and their application in therapeutics |
| 06/23/1999 | EP0923566A1 High molecular weight polymer-based prodrugs |
| 06/23/1999 | EP0923564A1 Pharmaceutical compounds |
| 06/23/1999 | EP0923563A1 1,4-heterocyclic metallprotease inhibitors |
| 06/23/1999 | EP0923561A1 Heterocyclic metalloprotease inhibitors |
| 06/23/1999 | EP0923557A1 Stereoselective deoxygenation reaction |
| 06/23/1999 | EP0923555A1 Carboxamide derivatives of pyrrolidine, piperidine and hexahydroazepine for the treatment of thrombosis disorders |